Anticipating the Future of the COVID-19 Pandemic

Anticipating the Future of the COVID-19 Pandemic

The initial instance of a severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection was observed in December 2019 in the city of Wuhan, China. Subsequently, the virus disseminated expeditiously across the globe,... read more

Thrombocytopenia Severity in COVID-19 Patients with Epstein-Barr Virus

Thrombocytopenia Severity in COVID-19 Patients with Epstein-Barr Virus

This study aimed to investigate the prevalence of viral co-infections in hospitalized patients and their potential association with platelet count (PLT) during hospitalization. Additionally, the study explored the gender... read more

Angiotensin-converting Enzyme 2 Polymorphisms and Susceptibility of Severe COVID-19

Angiotensin-converting Enzyme 2 Polymorphisms and Susceptibility of Severe COVID-19

Science is digging for the varied presentation of COVID-19 patients exposed to the same risk factors, and medical conditions may be influenced by the presence of polymorphic genetic variants. This study investigated the link... read more

Marburg Virus Disease Outbreaks in Equatorial Guinea and Tanzania

Marburg Virus Disease Outbreaks in Equatorial Guinea and Tanzania

The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to inform clinicians and public health departments in the United States about two confirmed outbreaks of Marburg... read more

Molnupiravir Improves Recovery Time in COVID-19 Patients at High Risk of Severe Outcomes

Molnupiravir Improves Recovery Time in COVID-19 Patients at High Risk of Severe Outcomes

This analysis of a large randomized trial involving people who are at high risk of experiencing severe outcomes from COVID-19 and who had been vaccinated against SARS-CoV-2 infection found that adding molnupiravir to usual... read more

China: Nearly 250 million people might be infected with COVID-19

China: Nearly 250 million people might be infected with COVID-19

According to a leaked government document that has been circulating on social media, it is estimated that up to 248 million people in China may have been infected with COVID-19 since control measures were lifted. This... read more

Inflammation Causes COVID-19-related Loss of Smell Not The Virus

Inflammation Causes COVID-19-related Loss of Smell Not The Virus

This study found that COVID-19 infection is associated with axon injuries and microvasculopathy in olfactory tissue. The striking axonal pathology in some cases indicates that olfactory dysfunction in COVID-19 infection may... read more

A Systematic Review of Indoor Air Sampling for COVID-19 Detection

A Systematic Review of Indoor Air Sampling for COVID-19 Detection

In a post-pandemic scenario, indoor air monitoring may be required seeking to safeguard public health, and therefore well-defined methods, protocols, and equipment play an important role. Considering the COVID-19 pandemic,... read more

COVID-19: Antibody-Dependent Enhancement

COVID-19: Antibody-Dependent Enhancement

The simple definition of ADE is “raising antibodies that don’t protect, but actually make a viral infection even worse”. And obviously, that’s the opposite of what you want. Remember that there are “neutralizing”... read more

The Impact of Defibrillation on Aerosol Generation During CPR

The Impact of Defibrillation on Aerosol Generation During CPR

Chest compressions alone did not cause significant aerosol generation in this swine model. However, increased aerosol generation was detected during chest compression immediately following defibrillation. Additional research... read more

How to be EPIC in the COVID-19 Era

How to be EPIC in the COVID-19 Era

Evolution is afoot. It's entirely possible you have noticed somewhat of an alteration in the world around us. A pandemic—the downwind effect of a miniscule strand of RNA and its lollipop-studded shell, a savage little virus... read more

FDA Authorized First Point-of-Care Antibody Test for COVID-19

FDA Authorized First Point-of-Care Antibody Test for COVID-19

U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first serology (antibody) point-of-care (POC) test for COVID-19. The Assure COVID-19 IgG/IgM Rapid Test Device was first authorized for... read more

COVID-19: Airborne Particle Contamination Increased Substantially Using the Aerosol Box

COVID-19: Airborne Particle Contamination Increased Substantially Using the Aerosol Box

Study shows that aerosol box used to protect healthcare workers during COVID intubation increases, rather than decreases, exposure to airborne particles. A new study shows that aerosol boxes that have been manufactured... read more

The COVID-19 Coronavirus is Changing

The COVID-19 Coronavirus is Changing

When a handful of doctors in northern Italy recently claimed that the virus that causes COVID-19 appears to be losing steam, that it no longer seems to be the same “biological bomb” it was when the pandemic first hit,... read more